Previous 10 | Next 10 |
Shareholder rights law firm Robbins Arroyo LLP announces that a purchaser of Acer Therapeutics Inc. (NASDAQ: ACER) filed a class action complaint for alleged violations of the Securities Exchange Act of 1934 between September 25, 2017 and June 24, 2019. Acer Therapeutics is a pharmaceutical...
Restructuring expected to extend cash runway through end of 2020 Acer plans to discuss EDSIVO™ CRL with FDA and will continue to advance additional pipeline products NEWTON, Mass., July 05, 2019 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical compa...
Glancy Prongay & Murray LLP (“GPM”) announces an investigation on behalf of Acer Therapeutics Inc. (“Acer” or the “Company”) (NASDAQ: ACER ) investors concerning the Company and its officers’ possible violations of federal securities laws....
NEW YORK , July 3, 2019 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Acer Therapeutics Inc. ("Acer" or the "Company") (NASDAQ: ACER) of the August 30, 2019 deadline to seek the role of lead plaintiff in a federal securities ...
NEW YORK, July 02, 2019 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a class action lawsuit has been filed against Acer Therapeutics, Inc. (“Acer” or the “Company”) (Nasdaq: ACER) in the United States District Court for the Southern District o...
Hindsight is always 20/20, and it’s the same in hindsight investing. Here, I’d like to address Acer Therapeutics’ ( ACER ) failure with Edsivo (celiprolol) for vascular Ehlers-Danlos syndrome (vEDS). The FDA’s rejection can teach investors, myself included, valuab...
Acer Therapeutics Inc. (NASDAQ: ACER ) ("Acer" or the "Company") is a pharmaceutical company headquartered in Newton, Massachusetts, focused on the acquisition, development, and commercialization of therapies for serious rare and life-threatening orphan or ultra-orphan diseases with signific...
Gainers: Cemtrex (NASDAQ: CETX ) +120% . The Howard Hughes (NYSE: HHC ) +38% . J.Jill (NYSE: JILL ) +21% . Foresight Autonomous Holdings (NASDAQ: FRSX ) +21% . Zogenix (NASDAQ: ZGNX ) +21% . Herman Miller (NASDAQ: MLHR ) +18% . Atossa Genetics (NASDAQ: ATOS ) +16% . Dova...
Gainers: Pyxus International (NYSE: PYX ) +28% . Allergan (NYSE: AGN ) +26% . ENDRA Life Sciences (NASDAQ: NDRA ) +23% . Pier 1 Imports (NYSE: PIR ) +18% . Rafael Holdings (NYSEMKT: RFL ) +16% . Riot Blockchain (NASDAQ: RIOT ) +15% . Vislink Technologies (NASDAQ: VISL ) +15% ....
Acer Therapeutics (NASDAQ: ACER ) -79% after FDA rejects Edsivo application for rare connective tissue disorder. More news on: Acer Therapeutics Inc., Cemtrex, Inc., Aldeyra Therapeutics, Inc., Stocks on the move, Read more ...
News, Short Squeeze, Breakout and More Instantly...
Acer Therapeutics Inc. Company Name:
ACER Stock Symbol:
NASDAQ Market:
Acer Therapeutics Inc. Website:
AERWINS Technologies Inc. (AWIN) is expected to report for Q1 2024 Minera IRL Ltd ADR (MRLLY) is expected to report for quarter end 2023-09-30 SmileDirectClub, Inc. - Ordinary Shares - Class A (SDCCQ) is expected to report $-0.1 for Q3 2023 NextPlay Technologies Inc. (NXTP) is expecte...
INVO BioScience Inc. (INVO) is expected to report for Q3 2023 HIVE Blockchain Technologies Ltd (HIVE) is expected to report $-0.13 for Q2 2024 BioNexus Gene Lab Corp (BGLC) is expected to report for Q1 2024 Adhera Therapeutics Inc (ATRX) is expected to report for Q1 2024 Altus Pow...
Acer Therapeutics Inc. (ACER) is expected to report $-0.13 for Q3 2023